Drug intelligence / Profile preview

folic acid + proguanil + Jobelyn

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination regimen consisting of three components: - **Folic acid** (a synthetic form of vitamin B9) is essential for DNA synthesis and repair, red blood cell formation, and prevention of anemia. - **Proguanil** (marketed as Paludrine) is an antimalarial agent that acts as a prodrug; its active metabolite cycloguanil inhibits the malaria parasite's dihydrofolate reductase, disrupting folate metabolism in the parasite and preventing its replication[4][6][9]. - **Jobelyn** is a proprietary extract derived from Sorghum bicolor. It has been studied for its antioxidant properties and potential to improve hematological parameters such as hemoglobin levels. It may also have anti-inflammatory effects[1][3][7]. This combination has been used in clinical studies involving patients with sickle cell anemia to support hematopoiesis, prevent malaria (especially in endemic regions), and provide antioxidant benefits[1][7]. Folic acid supplementation is particularly important when using proguanil due to possible depletion of body stores by the drug[4]. Jobelyn may further contribute to improved hemoglobin levels and immune function through its phytochemical content[3].

Brand names
PaludrineJobelyn
Other names
folic acid + Paludrine + Jobelyn
02

Targets

DHFR-TS (Bifunctional dihydrofolate reductase-thymidylate synthase)

Beyond the preview

Go deeper on folic acid + proguanil + Jobelyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on folic acid + proguanil + Jobelyn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call